- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06767787
Morbid Obesity and Severe Knee Osteoarthritis - Which Should Be Treated First?
Morbid Obesity and Severe Knee Osteoarthritis - Which Should Be Treated First? a Randomized Cross-over Study
The goal of this study is to determine whether undergoing bariatric surgery before knee replacement leads to better outcomes compared to undergoing knee replacement before bariatric surgery. Our secondary goal is to compare complication rates between these groups to determine if there is a difference based on the order of the two procedures.
Participants will be randomly placed in one of two groups, with each undergoing both procedures but in opposite order. Quality of life will be assessed via questionnaires before and between each procedure, and rates of complications will also be documented to compare their rates between groups.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Daniel G Muller, MD
- Phone Number: 647-227-1629
- Email: dmuller@mun.ca
Study Contact Backup
- Name: Jack A Kerr, MD
- Phone Number: 506-608-5005
- Email: jamkerr@mun.ca
Study Locations
-
-
Newfoundland and Labrador
-
St. John's, Newfoundland and Labrador, Canada, A1B3X5
- Health Sciences Centre
-
Contact:
- Jack A Kerr, MD
- Phone Number: 506-608-5005
- Email: jamkerr@mun.ca
-
Contact:
- Daniel G Muller, MD, MHSc
- Phone Number: 6472271629
- Email: dmuller@mun.ca
-
Contact:
- Daniel G Muller, MD, MHSc
-
Contact:
- Jack A Kerr, MD
-
St. John's, Newfoundland and Labrador, Canada, A1C5B8
- St. Clare's Mercy Hospital
-
Contact:
- Jack A Kerr, MD
- Phone Number: 506-608-5005
- Email: jamkerr@mun.ca
-
Contact:
- Daniel G Muller, MD, MHSc
-
Contact:
- Jack A Kerr, MD
-
Contact:
- Daniel G Muller, MD, MHSc
- Phone Number: 647-227-1629
- Email: dmuller@mun.ca
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- BMI > or = 35, on surgical waitlist for a total knee arthroplasty and laparoscopic sleeve gastrectomy
Exclusion Criteria:
- a history of revision surgery, surgery for neoplastic disease, significant mental illness, ASA class > 3 denoting absence of significant impact of comorbidities, and previous esophagogastric surgery.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Sleeve Gastrectomy then Knee Arthroplasty
Participants in this arm will undergo laparoscopic sleeve gastrectomy followed by a total knee arthroplasty at least 1 year following the first procedure.
|
Participants undergoing laparoscopic sleeve gastrectomy (LSG) will be clinically assessed and provided consent to this procedure by one of the bariatric surgeons affiliated with the bariatric surgery program.
LSG will be performed at a local tertiary care hospital as either a day procedure or as an overnight stay if medically indicated.
Patients will be discharged once they can tolerate a liquid diet.
Patients will then attend regular follow-ups with their surgeons and the bariatric surgery program, in accordance with a standardized clinical pathway protocol.
Other Names:
Patients undergoing unilateral total knee arthroplasty (TKA) will be clinically assessed and provided consent to their procedure by an orthopaedic surgeon trained in joint arthroplasty.
TKA will be performed at a local tertiary care hospital as either a day procedure or as an overnight stay if medically indicated.
Patients will be discharged once physiotherapy clears them.
Patients will attend regular follow-ups with their surgeon in accordance with a standardized clinical pathway protocol.
Other Names:
|
|
Active Comparator: Knee Arthroplasty then Sleeve Gastrectomy
Participants in this arm will undergo total knee arthroplasty followed by laparoscopic sleeve gastrectomy at least 1 year following the first procedure.
|
Participants undergoing laparoscopic sleeve gastrectomy (LSG) will be clinically assessed and provided consent to this procedure by one of the bariatric surgeons affiliated with the bariatric surgery program.
LSG will be performed at a local tertiary care hospital as either a day procedure or as an overnight stay if medically indicated.
Patients will be discharged once they can tolerate a liquid diet.
Patients will then attend regular follow-ups with their surgeons and the bariatric surgery program, in accordance with a standardized clinical pathway protocol.
Other Names:
Patients undergoing unilateral total knee arthroplasty (TKA) will be clinically assessed and provided consent to their procedure by an orthopaedic surgeon trained in joint arthroplasty.
TKA will be performed at a local tertiary care hospital as either a day procedure or as an overnight stay if medically indicated.
Patients will be discharged once physiotherapy clears them.
Patients will attend regular follow-ups with their surgeon in accordance with a standardized clinical pathway protocol.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
SF-36 Physical Function Component Score
Time Frame: At baseline/enrollment followed by a year following each procedure.
|
The 36-Item Short-Form Survey (SF-36) Physical Function Component Score will be assessed 1 year after each procedure as a measure of quality of life.
|
At baseline/enrollment followed by a year following each procedure.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
SF-36 Mental Component Score
Time Frame: At baseline/enrolment followed by a year after each procedure
|
The 36-Item Short Form Survey's (SF-36) Mental Component Score will be used to assess participants' quality of life at baseline in addition to after each procedure.
|
At baseline/enrolment followed by a year after each procedure
|
|
Knee Osteoarthritis Outcome Score (KOOS)
Time Frame: At baseline/enrolment in addition to a year following each procedure
|
The KOOS will be used to assess knee-specific function and symptoms at baseline as well as after each procedure.
|
At baseline/enrolment in addition to a year following each procedure
|
|
Post-Operative Outcomes
Time Frame: At 12 and 24 months following each intervention
|
Post-operative outcomes following each intervention will be collected, including: hospital bed-day utilization, change in BMI and weight at 12 and 24 months.
|
At 12 and 24 months following each intervention
|
|
Post-Operative Complications
Time Frame: Surveilled every 3 months post- each procedure, until the 12-month postoperative mark.
|
Post-operative complications will be surveilled every 3 months following each procedure, including: death from any cause, perioperative or postoperative complications that result in a delay in discharge (e.g., fracture, neurapraxia, sepsis, nosocomial infection, myocardial infarction, bowel obstruction, postoperative nausea & vomiting, venous thromboembolism, cerebrovascular event, and renal failure), wound complications (e.g., infections, hematomas, and dehiscence), prosthetic infection, and unplanned procedures and/or readmission.
|
Surveilled every 3 months post- each procedure, until the 12-month postoperative mark.
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HREB Application No. 38151
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteoarthritis of Knee
-
Edin MešanovićCompletedOsteoarthritis | Osteoarthritis of the Knee | Osteoarthritis of Knee | Osteoarthritis of the Knees | Osteoarthritis (OA) of the Knee | Osteoarthritis Knee | Osteoarthritis in the Knee | Osteoarthritis of Knee JointBosnia and Herzegovina
-
Joseph E. BroylesCompletedDegenerative Lesion of Articular Cartilage of Knee | Degeneration; Articular Cartilage, Knee | Unilateral Primary Osteoarthritis of Knee | Osteoarthritis Knee
-
Feza Korkusuz MDDr. Özgür Oktay Nar Private Clinic, Bursa, Türkiye; Contura International A... and other collaboratorsCompletedOsteoarthritis | Knee Osteoarthritis | Osteoarthritis of the Knee | Degenerative Joint Disease of the KneeTurkey (Türkiye)
-
DALIM TISSEN Co., Ltd.RecruitingOsteoarthritis | Knee Osteoarthritis | Degenerative Joint Disease of Knee | Cartilage Defects of the Knee | Knee Pain ArthritisSouth Korea
-
CrystalGenomics, Inc.CompletedLocalized Primary Osteoarthritis of Hip | Localized Primary Osteoarthritis of KneeKorea, Republic of
-
zhoupingBeijing Friendship Hospital; Beijing Jishuitan HospitalUnknownOsteoarthritis Of KneeChina
-
Universidade Nova de LisboaHospital de Santa Maria, Portugal; NOVA Medical School; Hospital de Egas Moniz; Instituto de Medicina Molecular João Lobo Antunes and other collaboratorsUnknown
-
Golden Jubilee National HospitalJohnson & Johnson; DePuy OrthopaedicsNot yet recruitingOsteoarthritis | Knee Osteoarthritis | Osteoarthritis (OA) | Osteo Arthritis | Osteoarthritis in the Knee | Osteoarthritis (Knee) | Osteo Arthritis of the KneeUnited Kingdom
-
Stempeutics Research Pvt LtdStempeutics Research Malaysia SDN BHDCompleted
-
Government Medical College, BhavnagarCompletedOsteoarthritis of Knee JointIndia
Clinical Trials on laparoscopic sleeve gastrectomy
-
King Saud UniversityNew You Medical CenterCompleted
-
Sengkang General HospitalSingapore General HospitalRecruitingObesity | Gastroesophageal Reflux | Bariatric Surgery Candidate | Esophagus InjurySingapore
-
Ankara UniversityCompletedObesity & OverweightTurkey (Türkiye)
-
Mohammad DaboosCompletedPediatric Obesity | Morbid Obesity | LAP
-
Umraniye Education and Research HospitalCompletedPostoperative Complications | Bleeding | Postoperative Nausea and VomitingTurkey
-
University of FoggiaCompletedBleeding | Obesity, Morbid | Bariatric Surgery Candidate | Leak, AnastomoticItaly
-
Sercan YUKSEL, MDCompletedMorbid Obesity Requiring Bariatric SurgeryTurkey (Türkiye)
-
Sercan YUKSEL, MDCompletedMorbid Obesity Requiring Bariatric SurgeryTurkey (Türkiye)
-
Yigit DUZKOYLUActive, not recruitingMorbid Obesity Requiring Bariatric SurgeryTurkey (Türkiye)
-
Centre Hospitalier Universitaire, AmiensCompleted